| Identification and validation of three miRNAs (miR-124, miR-147 and miR-193a-3p) as novel tumor suppressors that co-target EGFR-driven cell-cycle network proteins and inhibit cell-cycle progression and proliferation in breast cancer. | breast, |
| These findings indicate that miR-214 serves as tumor suppressor and plays substantial roles in inhibiting the tumorigenesis of hepatocellular carcinoma through suppression of beta-catenin. | liver, |
| these findings show that miR-124 functions as tumor suppressor in hepatocellular carcinoma (HCC) by targeting STAT3, and miR-124 may therefore serve as a biomarker for diagnosis and therapeutics in HCC. | liver, |
| study demonstrated that miR-124 might be a tumor suppressor in breast cancer via the regulation of FLOT1 | breast, |
| our findings suggest that miR-124 functions as a tumor suppressor by targeting STAT3, and that miR-124 may potentially serve as a useful biomarker for the prognosis of non-small cell lung cancer patients. | lung, |
| miR-124 functions as a tumor suppressor in esophageal cancer through, at least partially, targeting STAT3 signaling pathway. | esophageal, |
| MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1 | bladder, |
| miR-124 functions as a tumor suppressor in lung adenocarcinoma by directly targeting SOX9. | lung, |
| miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3 | glioblastoma, |
| MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer | lung, |
| The findings of the present study suggested that miR-124 functioned as tumor suppressor in retinoblastoma , at least in part, by targeting STAT3, and that it could serve as a potential candidate for retinoblastoma therapeutics. | retinoblastoma, |
| The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma | osteosarcoma, |
| miR-124 expression is decreased in breast cancer and plays an important role as a tumor suppressor gene by targeting SNAI2. | breast, |
| miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL | breast, |
| MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma | HNSC, |
| The demonstration that miR-124 inhibits gastric cancer cell growth supports the concept that miR-124 functions as a tumor suppressor by a mechanism that involves translational repression of the JAG1 and the inhibition of Notch signaling pathway. | gastric, |
| Circadian gene hCLOCK contributes to progression of colorectal carcinoma and is directly regulated by tumor?suppressive microRNA?124 | colorectal, |
| MicroRNA-124 acts as a tumor-suppressive miRNA by inhibiting the expression of Snail2 in osteosarcoma | osteosarcoma, |
| Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14 | lung, |
| miR-124 Functions As A Melanoma Tumor Suppressor By Targeting RACK1 | skin, |